Insights Into the Seroprevalence, Clinical Spectrum, and Laboratory Features of Dengue and Chikungunya Mono-Infections vs. Co-infections During 2022–2023
Rattachement africain : in. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Background Central India is hyperendemic for dengue and chikungunya virus infections, with yearly outbreaks being recorded. As these infections are clinically overlapping, co-infection of these viruses poses a diagnostic challenge. Therefore, it is imperative to identify them using serological or molecular tests. In this study, seroprevalence of dengue and chikungunya mono-infection as well as co-infections was estimated in suspected patients presented at our tertiary care center. Also, we compared the biochemical and other lab parameters of all the dengue and chikungunya mono-infected and co-infected IPD (Inpatient Department) patients. Methods A total of 3350 dengue and chikungunya suspected samples were recruited in this study. Sero-diagnosis of dengue was done using IgM MAC and NS-1 antigen enzyme-linked immunosorbent assay (ELISA), and chikungunya by IgM MAC ELISA. Further, we compared the demographic characteristics, temporal variations, clinical features, and biochemical parameters in patients with dengue and chikungunya mono-infection vs. co-infection. Results Seropositivity for dengue (DENV) and chikungunya (CHIKV) mono-infections was observed to be 23.86% (n=800) and 13.30% (n=444), respectively, while seropositivity for dengue and chikungunya co-infections was observed to be 6.55% (n=220). Leucopenia was significantly higher among the co-infected patients as compared to DENV and CHIKV mono-infected cases. Hypokalemia was significantly higher among the DENV patients and co-infected patients as compared to the CHIKV patients. Urea and creatinine levels were significantly elevated among the CHIKV patients as compared to DENV and co-infected patients. Conclusions Leucopenia and hypokalemia were found to be significantly high among the co-infected patients. Clinically suspected samples should be tested for both viruses, especially in the monsoon and post-monsoon seasons, as high sero-prevalence has been observed. Simultaneous diagnosis of these infections is required to diagnose dual infections and thus triage patients for monitoring and initiating supportive treatment to prevent fatal complications.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Insights Into the Seroprevalence, Clinical Spectrum, and Laboratory Features of Dengue and Chikungunya Mono-Infections vs. Co-infections During 2022–2023
- Date Crossref
- 15/09/2025
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.